Status:
ACTIVE_NOT_RECRUITING
Anisocoria in the Intensive Care Unit (AICU Study)
Lead Sponsor:
University Hospital, Basel, Switzerland
Conditions:
Anisocoria
Eligibility:
All Genders
18+ years
Brief Summary
This retrospective single-center cohort study aims to determine the prevalence of acute "new onset" pupillary abnormalities in adult intensive care unit patients, assess their clinical impact, identif...
Detailed Description
Assessment of the pupil symmetry and reactivity to light are important parts of the neurological evaluation of critically ill patients in intensive care units (ICUs). Anisocoria, a condition where the...
Eligibility Criteria
Inclusion
- Adult patients (i.e., patients ≥18 years of age)
- Reported incident of pupillary abnormality (either anisocoria or non-normal pupillary reactivity) in the intensive care unit at the University Hospital Basel between 2013-2024.
Exclusion
- Patients younger than 18 years
- Patients with documented refusal of data use.
Key Trial Info
Start Date :
March 1 2025
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2025
Estimated Enrollment :
920 Patients enrolled
Trial Details
Trial ID
NCT06964997
Start Date
March 1 2025
End Date
December 1 2025
Last Update
May 11 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Basel, Clinic for Intensive Care Medicine
Basel, Canton of Basel-City, Switzerland, 4031